Volume 22, Number 3—March 2016
Lyme Disease in Hispanics, United States, 2000–2013
Hispanics comprise a growing portion of the US population and might have distinct risk factors for tickborne diseases. During 2000–2013, a total of 5,473 Lyme disease cases were reported among Hispanics through national surveillance. Hispanics were more likely than non-Hispanics to have signs of disseminated infection and onset during fall months.
Lyme disease (LD) is caused by the spirochete Borrelia burgdorferi, transmitted to humans through the bite of infected Ixodes scapularis and I. pacificus ticks. Early localized infection typically manifests as erythema migrans with concomitant fever and malaise; disseminated infection can lead to facial palsy, carditis, arthritis, or neuropathy (1).
Outdoor workers in LD-endemic areas have increased odds of occupational exposure to ticks and a rate of LD seropositivity substantially higher than that of the general population (2,3). In the United States, Hispanics comprise 43.6% of grounds maintenance workers and 43.4% of workers in the farming, fishing, and forestry industries, potentially placing this population at greater risk for LD from occupational exposures (4).
An estimated 9 million Hispanics live in the 13 states with the highest reported incidence of LD, all of which are located in the Northeast, upper Midwest, and mid-Atlantic regions (5,6). Little is known, however, about the epidemiology of LD in the rapidly growing and diverse US Hispanic population. Improved understanding of LD in Hispanics could aid prevention efforts by public health practitioners and diagnosis by clinicians. The objective of this study was to describe the epidemiology of LD in the US Hispanic population and identify differences between Hispanics and non-Hispanics with LD by using national surveillance data.
LD is a nationally notifiable condition, and cases are reported by state and local health departments to the Centers for Disease Control and Prevention (CDC) through the National Notifiable Diseases Surveillance System in accordance with previously established protocols (7). LD cases reported during 2000–2007 were confirmed cases only. In 2008, a revised case definition was implemented that altered the laboratory criteria and distinguished between confirmed and probable cases; cases reported during 2008–2013 included both categories (8).
We used 2010 US Census population data to calculate incidence rates (5,9). Weighting was applied to state- and county-specific numbers of cases to account for variations in completeness of ethnicity data. Descriptive statistics and comparisons were calculated by using SAS version 9.3 (SAS Institute, Cary, NC, USA). We compared median age of Hispanics and non-Hispanics with LD using the Kolmogorov-Smirnov 2-sample test. Risk ratios (RRs) were used to compare categorical data.
CDC human subjects review of the protocol determined it was not research involving human subjects. Thus, Institutional Review Board approval was not required.
During 2000–2013, a total of 374,338 LD cases were reported to CDC, of which 148,444 (39.7%) reports contained information about ethnicity and were included in this analysis. Among these, 5,473 (3.7%) persons self-identified as being of Hispanic ethnicity. Most (54.8%) Hispanics with LD were male; median age was 32 years (interquartile range 15–46 years).
Annual incidence of reported LD among Hispanics was 0.8 cases/100,000 persons, compared with 4.0/100,000 among non-Hispanics. During 2000–2001, Hispanics comprised 2.8% of all persons with LD, whereas during 2009–2013, Hispanics comprised 3.7%–4.9% of persons with reported LD. In comparison, the proportion of Hispanics in the US population increased slightly during this period, from 13% in 2000 to 16% in 2010 (5).
Although a bimodal age distribution was evident among both Hispanics and non-Hispanics with LD, the peak in children was less pronounced among Hispanics (Figure). Highest incidence among Hispanic children was in boys 10–14 years of age, whereas among non-Hispanic children, incidence was highest in boys 5–9 years of age. In adults, highest incidence among both Hispanics and non-Hispanics was in men 65–74 years of age.
Hispanics were significantly less likely than non-Hispanics to have disease onset during the summer months (RR 0.85, 95% CI 0.83–0.88) and more likely to have disease onset during the fall months (RR 1.15, 95% CI 1.07–1.24) (Table 1). Although erythema migrans was the most commonly reported clinical feature for both groups, it was less commonly reported among Hispanics than non-Hispanics (RR 0.83, 95% CI 0.80–0.86). Manifestations of disseminated disease, such as arthritis and facial palsy, were more commonly reported among Hispanics than non-Hispanics (Table 1).
As expected, >90% of LD cases overall were reported from high-incidence states, although Hispanics with LD were slightly less likely to report residence in a high-incidence state (RR 0.90, 95% CI 0.82–0.98). All of the statistical associations were similar when analysis was restricted to confirmed cases only, with the exception of residence in a high-incidence state, which became nonsignificant (RR 0.99, 95% CI 0.89–1.10).
After weighting, nearly half of all estimated cases of LD among Hispanics were from New York or New Jersey (Table 2). Among counties with at least 75 estimated LD cases among Hispanics during the study period, highest incidence among Hispanics occurred in Columbia County, New York (170.4 cases/100,000 persons); Sussex County, New Jersey (111.4/100,000); and Hunterdon County, New Jersey (106.3/100,000).
Overall, the epidemiology of LD among Hispanics was similar to that among non-Hispanics: bimodal age distribution, slight predilection in males, and clustering in states to which LD is highly endemic were apparent (10). However, we identified several important differences. Most notably, Hispanics with LD were significantly more likely than non-Hispanics with LD to have signs of disseminated infection and symptom onset during fall months.
Although the overall incidence of LD in Hispanics was lower than that in non-Hispanics, additional research is needed to determine the reasons underlying these differences and the extent of any LD underdiagnosis in the Hispanic population. Inadequate healthcare access, language barriers, and lack of LD awareness could cause both underdiagnosis and delays in diagnosis in the Hispanic population. During 2009–2013, a total of 41.5% of Hispanics lacked health insurance, compared with 15.1% of non-Hispanic whites; 15.5% of Hispanics described delay in or nonreceipt of medical care because of cost (11). Furthermore, whether the predilection toward symptom onset in the fall months for Hispanics results from delays in medical care or other factors, such as seasonal outdoor labor patterns, is unclear. Lastly, because a larger proportion of Hispanics than the overall US population live in urban areas (12), the risk for LD might be differentially diluted in Hispanics.
Our findings were subject to several limitations. First, we had to exclude more than half of reported LD cases because of missing ethnicity data. Although we have no reason to believe that case reports with missing ethnicity data differed otherwise from those included in this study, we cannot exclude this possibility. Ethnicity reporting is also subject to error. Finally, surveillance data are limited by underreporting and reporting bias, which might differ by state and between Hispanic and non-Hispanic populations.
Reaching at-risk populations with culturally and linguistically appropriate prevention education is essential. Although some educational materials about prevention of tickborne diseases have been translated to Spanish (13,14), additional translations and modifications to address cultural differences would be helpful. Furthermore, targeted educational campaigns could enhance use of these materials and improve the reach, retention, and overall impact of prevention education.
We identified specific risk groups and patterns of LD within the US Hispanic population. Direct and more in-depth assessments regarding prevention practices, knowledge, and LD epidemiology on local and national scales will further the understanding of LD risk in this population and guide future targeted prevention and education efforts.
Dr. Nelson is a medical epidemiologist at CDC’s Bacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Fort Collins, Colorado. Her primary research interests are the epidemiology and clinical manifestations of LD, Bartonella infections, tularemia, and plague.
We thank Kalanthe Horiuchi for assistance with statistical analysis. We also thank state and local health department staff who contributed surveillance information.
- Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461–73.
- Schwartz BS, Goldstein MD. Lyme disease in outdoor workers: risk factors, preventive measures, and tick removal methods. Am J Epidemiol. 1990;131:877–85 .
- Smith PF, Benach JL, White DJ, Stroup DF, Morse DL. Occupational risk of Lyme disease in endemic areas of New York state. Ann N Y Acad Sci. 1988;539:289–301.
- US Department of Labor, Bureau of Labor Statistics. Labor force statistics from the current population study—employed persons by detailed occupation, sex, race, and Hispanic or Latino ethnicity [cited 2015 Oct 27]. http://www.bls.gov/cps/cpsaat11.pdf
- US Census Bureau. The Hispanic population: 2010. 2011 [cited 2015 Oct 27]. http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf
- Centers for Disease Control and Prevention. Lyme disease incidence rates by state. 2015 [cited 2015 Oct 27]. http://www.cdc.gov/lyme/stats/chartstables/incidencebystate.html
- Adams DA, Jajosky RA, Ajani U, Kriseman J, Sharp P, Onwen DH, Summary of notifiable diseases—United States, 2012. MMWR Morb Mortal Wkly Rep. 2014;61:1–121 .
- Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System. Lyme disease case definitions, 1995–2011 [cited 2015 Oct 27]. http://wwwn.cdc.gov/nndss/conditions/lyme-disease/
- US Census Bureau. 2010 Census demographic profile summary file. 2011 [cited 2015 Oct 27]. http://www.census.gov/2010census/data
- Bacon RM, Kugeler KJ, Mead PS; Centers for Disease Control and Prevention. Surveillance for Lyme disease—United States, 1992–2006. MMWR Surveill Summ. 2008;57:1–9 .
- Dominguez K, Penman-Aguilar A, Chang MH, Moonesinghe R, Castellanos T, Rodriguez-Lainz A, Vital signs: leading causes of death, prevalence of diseases and risk factors, and use of health services among Hispanics in the United States—2009–2013. MMWR Morb Mortal Wkly Rep. 2015;64:469–78 .
- Pew Hispanic Center. US-born Hispanics increasingly drive population developments [cited 2015 Nov 9]. http://www.pewhispanic.org/files/2011/10/2.pdf
- Centers for Disease Control and Prevention. Lyme disease communications tool kit [cited 2015 Oct 27]. http://www.cdc.gov/lyme/toolkit/index.html
- Connecticut Department of Public Health. Hoja informativa de la enfermedad de Lyme [cited 2015 Oct 27]. http://www.ct.gov/dph/cwp/view.asp?a=3136&q=400692
- Figure. Age- and sex-specific incidence of Lyme disease among Hispanics (A) and non-Hispanics (B), United States, 2000–2013. For persons >35 years, age categories are collapsed into 10-year intervals. Incidence is...
- Table 1. Demographic and clinical characteristics of Hispanics and non-Hispanics with LD, United States, 2000–2013
- Table 2. Locations with the highest number of estimated cases and incidence of LD among Hispanics, United States, 2000–2013
Suggested citation for this article: Nelson CA, Starr JA, Kugeler KJ, Mead PS. Lyme disease in Hispanics, United States, 2000–2013. Emerg Infect Dis. 2016 Mar [date cited]. http://dx.doi.org/10.3203/eid2203.151273
Please use the form below to submit correspondence to the authors or contact them at the following address:
Christina A. Nelson, Centers for Disease Control and Prevention, 3156 Rampart Rd, Mailstop P02, Fort Collins, CO 80521, USA
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: February 18, 2016
- Page last updated: February 18, 2016
- Page last reviewed: February 18, 2016
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)